At a Board meeting on April 22, 2013 in Mertiva AB (previously Diamyd Medical
AB), it was decided that the company should apply for delisting from NasdaqOMX.
It was also decided that the company should be listed on another equities
marketplace.
The date for the delisting from NasdaqOMX will be decided together with
NasdaqOMX. The intention is that the company should be listed on Aktietorget or
another similar equities marketplace at the same time as the share is delisted
from NasdaqOMX.
For more information, please contact:
info@mertiva.se
About Mertiva
Mertiva AB (former Diamyd Medical) primarily consists of holdings in liquid
assets and holdings in Protein Sciences Corporation and Mercodia AB.
Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small
Cap) in Stockholm (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY)
administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).
More information can be found at www.mertiva.se
This information is disclosed in accordance with the Swedish Securities Markets
Act, the Swedish Financial Instruments Trading Act, or the requirements stated
in the listing agreements.
Mertiva AB (publ)
Karlavägen 108, SE-115 26 Stockholm, Sweden.
E-mail: info@mertiva.com. Reg. no: 556530-1420
